U.S. emergency approval broadens use of Gilead’s COVID-19 drug remdesivir

By Steve Holland WASHINGTON (Reuters) - Gilead Science Inc's antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States

The post U.S. emergency approval broadens use of Gilead’s COVID-19 drug remdesivir appeared first on Firstpost.

from Firstpost